Restructuring watch

Restructuring watch

Date Company Staff cuts Cash Years cash pre-cut Cash date Oper loss for 12 mos ended 12/31
1/15/08 NitroMed (NASDAQ:NTMD) 89% to 10 $31.4 0.96 12/31/07 $32.8
Exploring strategic alternatives; discontinuing sales and promotional activities for BiDil, although the fixed-dose combination of hydralazine hydrochloride and disosorbide dinitrate will remain on the market to treat heart failure in black patients
1/21/08 Curalogic (CSE:CUR) 50% to 7 $64.6 1.58 12/31/07 $40.8
Aiming to secure a deal this year for new development projects after its ragweed allergy vaccine failed a Phase III trial
1/29/08 Neose (NASDAQ:NTEC) 40% to ~30 $19.3 0.52 12/31/07 $37.0

Read the full 1028 word article

How to gain access

Continue reading with a
two-week free trial.